Evidence map›Paper›PMID 29441323›Full record

ArticleJournal of advanced pharmaceutical technology & research

The ethanolic extract of ashitaba stem (

Sri Agung Fitri Kusuma, Yoppi Iskandar, Mutiara Ayu Dewanti

Open access · goldAbstract read
In one paragraph

Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sri Agung Fitri KusumaDepartment of Biology Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jawa Barat, Indonesia.
Yoppi IskandarDepartment of Biology Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jawa Barat, Indonesia.
Mutiara Ayu DewantiDepartment of Biology Pharmacy, Faculty of Pharmacy, Padjadjaran University, Jawa Barat, Indonesia.
Padjadjaran University · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Considering the easy contagion of tuberculosis (TB) disease spread and the emergence of multidrug-resistant TB, which directly impacts the failure of therapeutic goals and mortality rates increasing, TB disease control remains to be the main concern of continuous health development effort. Therefore, the discovery of new TB drug is needed. This research assessed the new natural anti-TB drug from the ethanolic extract of

Indexed as

Angelica keiskeiIndonesiaminimum inhibitory concentrationMycobacterium tuberculosis H37Rvtuberculosis

Identifiers

PMID29441323
PMCPMC5801586
OpenAlexW2791620795

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.